Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$3.45
-0.3%
$2.57
$1.51
$12.00
$243.40M1.992.34 million shs1.40 million shs
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$16.62
+0.2%
$19.40
$2.26
$41.72
$178.84M1.4927,689 shs6,578 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$4.69
+4.3%
$3.87
$2.56
$15.84
$223.01M2.031.18 million shs455,928 shs
PARK
Park Dental Partners
$17.81
+5.5%
$17.69
$9.53
$21.59
$80.41MN/A36,181 shs6,720 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-3.08%+29.10%+17.69%+52.42%+35.16%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-2.53%-2.47%+3.05%-51.24%+614.66%
LifeMD, Inc. stock logo
LFMD
LifeMD
-14.80%-4.06%+30.90%+42.99%-44.12%
PARK
Park Dental Partners
-2.58%-3.41%-4.55%-1.27%+1,698,099,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$3.45
-0.3%
$2.57
$1.51
$12.00
$243.40M1.992.34 million shs1.40 million shs
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$16.62
+0.2%
$19.40
$2.26
$41.72
$178.84M1.4927,689 shs6,578 shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$4.69
+4.3%
$3.87
$2.56
$15.84
$223.01M2.031.18 million shs455,928 shs
PARK
Park Dental Partners
$17.81
+5.5%
$17.69
$9.53
$21.59
$80.41MN/A36,181 shs6,720 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-3.08%+29.10%+17.69%+52.42%+35.16%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-2.53%-2.47%+3.05%-51.24%+614.66%
LifeMD, Inc. stock logo
LFMD
LifeMD
-14.80%-4.06%+30.90%+42.99%-44.12%
PARK
Park Dental Partners
-2.58%-3.41%-4.55%-1.27%+1,698,099,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
1.50
Reduce$6.0073.91% Upside
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1.00
SellN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
2.67
Moderate Buy$9.1495.15% Upside
PARK
Park Dental Partners
2.75
Moderate Buy$21.7522.13% Upside

Current Analyst Ratings Breakdown

Latest PARK, LFMD, AIRS, and BNR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/4/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingBuy$10.00
4/27/2026
PARK
Park Dental Partners
DowngradeSell (E+)Sell (E)
4/20/2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
Reiterated RatingSell (D-)
3/27/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingSell (E+)
3/16/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
UpgradeNeutralOutperform$6.00 ➝ $8.00
3/12/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Set Price Target$10.00
3/11/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Boost Price TargetBuy$9.00 ➝ $10.00
3/10/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingOverweight
3/10/2026
LifeMD, Inc. stock logo
LFMD
LifeMD
Reiterated RatingBuy$10.00
3/2/2026
PARK
Park Dental Partners
Initiated CoverageSell (E)
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$151.82M1.60$0.02 per share200.09$1.40 per share2.46
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$77.16M2.32N/AN/A$7.11 per share2.34
LifeMD, Inc. stock logo
LFMD
LifeMD
$194.05M1.15N/AN/A$0.48 per share9.76
PARK
Park Dental Partners
$244.49M0.33N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$11.67M-$0.19N/AN/AN/A-7.68%-5.01%-2.19%5/8/2026 (Estimated)
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$7.92M-$0.79N/AN/AN/A-10.27%-9.98%-6.69%6/2/2026 (Estimated)
LifeMD, Inc. stock logo
LFMD
LifeMD
$14.35M$0.2693.7210.18N/A2.37%-176.40%-22.61%N/A
PARK
Park Dental Partners
N/AN/AN/A12.11N/AN/AN/AN/AN/A

Latest PARK, LFMD, AIRS, and BNR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/2/2026Q1 2026
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$2.2884N/AN/AN/A$19.21 millionN/A
5/8/2026Q4 2025
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$0.02-$0.01+$0.01-$0.03$39.20 million$39.39 million
5/6/2026Q1 2026
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.14-$0.20-$0.06-$0.20$48.84 million$50.16 million
3/31/2026Q4 2025
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$0.02-$0.02N/A$0.02N/A$33.44 million
3/31/2026Q4 2025
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$0.03$0.02+$0.05$0.02$34.93 million$33.44 million
3/13/2026Q4 2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A-$0.21N/A-$0.21N/A$18.05 million
3/9/2026Q4 2025
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.01-$0.04-$0.03$0.41$48.57 million$46.87 million
2/25/2026Q4 2025
PARK
Park Dental Partners
-$0.07$0.30+$0.37-$2.31$59.20 million$61.21 million
2/14/2026Q4 2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A-$0.21N/A-$0.21N/A$18.05 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
N/AN/AN/AN/AN/A
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
PARK
Park Dental Partners
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
0.58
0.55
0.55
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A
2.99
2.79
LifeMD, Inc. stock logo
LFMD
LifeMD
N/A
1.25
1.18
PARK
Park Dental Partners
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
91.54%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.03%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
PARK
Park Dental Partners
N/A

Insider Ownership

CompanyInsider Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
44.60%
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.30%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.40%
PARK
Park Dental Partners
10.56%
CompanyEmployeesShares OutstandingFree FloatOptionable
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
24070.55 million39.08 millionOptionable
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1,39010.76 million7.50 millionNot Optionable
LifeMD, Inc. stock logo
LFMD
LifeMD
23047.60 million38.84 millionOptionable
PARK
Park Dental Partners
1,2084.52 million4.04 millionN/A

Recent News About These Companies

Park Dental opens Minnesota practice
Park Dental Partners
12 notable dental deals in Q1
70+ DSO affiliations in Q1: State-by-state breakdown
3 DSOs nearing 100 offices
Park Dental Partners Announces Fourth Quarter and Full-Year Results
Park Dental Partners Inc PARK
Park Dental Partners adds 2nd practice in Arizona

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AirSculpt Technologies stock logo

AirSculpt Technologies NASDAQ:AIRS

$3.46 0.00 (0.00%)
As of 01:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$16.62 +0.04 (+0.25%)
As of 01:16 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

LifeMD stock logo

LifeMD NASDAQ:LFMD

$4.68 +0.20 (+4.34%)
As of 01:26 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Park Dental Partners NASDAQ:PARK

$17.81 +0.93 (+5.50%)
As of 01:18 PM Eastern
This is a fair market value price provided by Massive. Learn more.

As a dental resource organization (“DRO”) operating through Park Dental Partners, Inc., and subsidiaries, we provide comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to our affiliated general and multi-specialty dental practices (which are not legal subsidiaries) throughout Minnesota and Wisconsin. Our network of affiliated dental practices employs over 200 dentists across 84 practice locations and was ranked as one of Minnesota’s largest private companies by revenue by the Minneapolis/St Paul Business Journal in June 2025. Our clinical support team includes over 900 hygienists, dental assistants, and patient care coordinators that support affiliated dentists in operating their dental practices. Our network of affiliated dental practices has been operating for over fifty years, beginning with the establishment of the general dentistry group in 1972. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today. Our network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30 years, with automatic 5-year renewals. We have established a significant footprint and brand awareness in our current markets. Our revenues, derived primarily from our affiliated dental practices’ provision of dental services, were approximately $183.3 million and $172.9 million for the nine months ended September 30, 2025 and 2024, respectively, and were approximately $229.8 million and $223.5 million for the years ended December 31, 2024 and 2023, respectively. Our material revenues are comprised of dental services, which includes the consolidated revenues of our affiliated dental practices. Dental services are provided to patients, who typically pay for services through private insurance plans, government insurance plans, or directly. Approximately 91% and 93% of total revenues for each of the nine months ended September 30, 2025, and 2024, respectively, and approximately 93% of total revenues for each of the years ended December 31, 2024 and 2023, respectively, were derived from patients with private insurance or government sponsored plans. Dental care patients tend to be price-sensitive because many pay for a significant portion of their dental expenses on an out-of-pocket basis. We have steadily grown by adding new dentists and team members, expanding existing practices, implementing operating efficiencies, and by acquiring existing practices. Our organic expansion includes opening de novo practices, which are new practice locations opened with our affiliated dentists in existing or new markets. Since the start of calendar 2014 we have acquired 40 practices and opened 11 de novo practices. On average, de novo practices are cash flow positive within approximately six months, meaning that the practice location monthly Gross Margin excluding depreciation is positive. Of the 11 de novo practices opened since 2014, more than 80% were cash flow positive within six months. We attribute this success to our established model that streamlines day-to-day dental practice operations by providing key business and administrative resources, allowing dentists and team members to focus on patient care. We plan to expand our existing general and multi-specialty dental brands, establishing a group of successful, respected dental practices. Dentists hold a majority interest in our organization, which we believe is a key differentiator between our model and those of our competitors. Our model provides our affiliated dentists with significant organizational input because our affiliated dentists, who are majority shareholders in the business, are directly involved in our governance through their right to appoint three directors to the Board of Directors. We believe this right helps ensure that our affiliated dentists maintain a professional voice in governance that helps focus the organization on ensuring patients enjoy the benefits of a lifetime of good oral health. We believe this compelling model allows for greater input and provides enhanced stewardship for dentists, which assists with attracting and retaining dental professionals and serves as a catalyst for future growth. By contrast, we believe traditional dental organization ownership structures, many of which are funded by private equity, introduce constraints and concessions that limit dentists’ clinical autonomy and can restrict or omit dentists’ professional voice in governance. --- Our affiliated dental practices have been in operation since the founding of Park Dental in 1972. In May 2023, the owners of our affiliated dental practices established a dental resource organization 100% owned by dentists and management, through the creation of Park Dental Partners, Inc. and transitioned to the new operating structure on October 1, 2023. Park Dental Partners, Inc was incorporated in the state of Minnesota in 2023 to act as a dental resource organization for the operating affiliated dental practices. Our principal executive offices are located in Roseville, Minnesota.